Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	322.49	275.47	341.93	366.89	246.05	314.8
Cash & Short-Term Investments	322.49	275.47	341.93	366.89	246.05	314.8
Cash Growth	13.89%	-19.44%	-6.80%	49.11%	-21.84%	-25.65%
Accounts Receivable	467.21	462.13	422.56	387.8	472.06	388.16
Other Receivables	0.59	0.01	0	0	0	0
Receivables	467.79	462.14	422.56	387.8	472.06	388.16
Inventory	411.96	361.67	345.62	348.99	369.35	291.96
Prepaid Expenses	43.91	41.91	44.93	28.77	25.42	23.17
Total Current Assets	1,246	1,141	1,155	1,132	1,113	1,018
Property, Plant & Equipment	1,453	1,459	1,518	1,526	1,543	1,035
Long-Term Investments	322.72	333.08	324.34	331.74	313.75	293.55
Other Intangible Assets	36.1	37.87	27.57	24.13	22.96	23.42
Long-Term Deferred Tax Assets	14.62	16.89	18.86	17.44	16.21	12.32
Other Long-Term Assets	68.52	58.22	38.4	73.21	58.7	28.23
Total Assets	3,141	3,048	3,085	3,106	3,071	2,416

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	273.94	234.75	255.87	226.47	248.45	236.86
Accrued Expenses	-	83.56	78.84	72.8	79.89	64.72
Short-Term Debt	70	-	-	80	230	-
Current Portion of Long-Term Debt	-	59.03	59.03	59.03	-	-
Current Portion of Leases	16.06	15.17	14.71	13.38	14.85	13.7
Current Income Taxes Payable	9.44	33.55	35.18	62.06	76.99	58.39
Current Unearned Revenue	62.58	37.16	24.83	20.04	6.73	6.55
Other Current Liabilities	156.43	56.37	51.7	50.81	62.56	38.4
Total Current Liabilities	588.45	519.58	520.16	584.58	719.47	418.61
Long-Term Debt	-	4.92	163.95	222.97	182	50
Long-Term Leases	142.56	146.08	160.25	163.1	173.93	172.39
Long-Term Deferred Tax Liabilities	3.34	4.32	4.17	3.98	3.93	3.16
Other Long-Term Liabilities	1.5	-	-	-	-	-
Total Liabilities	735.85	674.89	848.52	974.63	1,079	644.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	271.01	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	611.04	618.36	618.24	618.2	618.06	612.83
Retained Earnings	1,512	1,480	1,344	1,243	1,103	887.88
Comprehensive Income & Other	11.27	3.54	2.73	-0.26	-0.07	-0.36
Shareholders' Equity	2,405	2,373	2,236	2,132	1,992	1,771
Total Liabilities & Equity	3,141	3,048	3,085	3,106	3,071	2,416

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	228.61	225.19	397.93	538.49	600.78	236.08
Net Cash (Debt)	93.88	50.27	-56	-171.6	-354.73	78.72
Net Cash Growth	-	-	-	-	-	-54.53%
Net Cash Per Share	3.46	1.85	-2.06	-6.33	-13.07	2.90
Filing Date Shares Outstanding	27.11	27.1	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.11	27.1	27.1	27.1	27.1	27.1
Working Capital	657.7	621.61	634.89	547.87	393.41	599.48
Book Value Per Share	88.71	87.57	82.51	78.66	73.49	65.36
Tangible Book Value	2,369	2,335	2,209	2,107	1,969	1,748
Tangible Book Value Per Share	87.38	86.17	81.49	77.76	72.64	64.50
Land	-	251	251	251	251	-
Buildings	-	820.48	729.7	717.09	702.28	532.98
Machinery	-	1,052	1,022	871.44	841.51	693.37
Construction In Progress	-	3.49	74.67	146.33	114.01	111.97

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error